Want to join the conversation?
$PFE 1Q15 10-Q: On Feb. 5, 2015, PFE have entered into a definitive merger agreement under which it has agreed to acquire Hospira, Inc., a leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, for $90 per share in cash, for a total enterprise value of approx. $17Bil and is expected to close in 1H15.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!